Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism is a research paper published in Addiction Neuroscience (2024). On theSindex it has a DataRank of 0.609. It has been cited 57 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.609
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FDA
Grant: U01FD007857
National Institute of Mental Health
Grant: HHSN-271-2018-00023-C
National Institute on Drug Abuse
Grant: F31DA05621
National Institute on Drug Abuse
Grant: R01DA049261
NIAAA NIH HHS
Grant: T32 AA007573
NIDA NIH HHS
Grant: F31 DA056211
NIDA NIH HHS
Grant: F31 DA005621
National Institutes of Health
Grant: 1F31DA005621-01
PRENATAL COCAINE AND SOCIAL BEHAVIORS OVER ONTOGENY
National Institutes of Health
Grant: 5U01FD007857-03
Research Triangle Center of Excellence in Regulatory Science and Innovation
National Institutes of Health
Grant: 5R01DA049261-05
Noradrenergic Plasticity in Opioid Withdrawal
Collaboratory
North Carolina Department of Health and Human Services
NIH
North Carolina General Assembly
FWCI
10.79
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals